Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia

NCT05135286 is registered in ClinicalTrials.gov with Visus Therapeutics as lead sponsor.

NCT NCT05135286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05135286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia
Lead sponsor
Visus Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
March 15, 2022
Completion date
March 13, 2025
Enrollment
629 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia